From geneedited cell therapy to CART therapy and more researchers are developing treatments specifically for pediatric patients. Learn more about the nearly 600 medicines in development in the new report at httpsonphr.ma3bQiMUPÂpic.twitter.comSu

From gene-edited cell therapy to CAR-T therapy and more, researchers are developing treatments specifically for pediatric patients. Learn more about the nearly 600 medicines in development in the new report at https://onphr.ma/3bQiMUP pic.twitter.com/Su

09:00 EST 24 Feb 2020 | PhRMA

From gene-edited cell therapy to CAR-T therapy and more, researchers are developing treatments specifically for pediatric patients. Learn more about the nearly 600 medicines in development in the new report at https://onphr.ma/3bQiMUP pic.twitter.com/Su4RUz2PI7